Heart Failure

CV risk should be comprehensively assessed before noncardiac surgery, including a thorough history and physical examination, researchers found in a review.

Beta-blocker use may precipitate HF in women with new-onset CHD but not in men, researchers found.

Patients with HF who had insufficient calorie intake had increased burden of readmission and a poor quality of life after discharge, according to findings from the GOURMET-HF trial.

Researchers have identified a link between preterm delivery and future maternal risk for ischemic heart disease. It was the top story in cardiology last week.

The FDA has designated Arrow International’s recall of two intra-aortic balloon pumps as a class 1 recall, the most serious kind.

In HF with reduced ejection fraction, factors such as HF duration, nonischemic cardiomyopathy and no coronary disease may be linked to improvements in left ventricular ejection fraction and better outcomes, researchers reported.

Danicamtiv, a novel cardiac myosin activator, improved left ventricular systolic function and left atrial volume and function for patients with HF with reduced ejection fraction in a phase 2a trial.

Details of a trial evaluating how providing young, Black adults with CV-related health coaching may promote healthy lifestyles and reduce the risk for CVD was the top story in cardiology last week.

Two interim analyses of the EMPRISE study supported the effectiveness and CV safety of the SGLT2 inhibitor empagliflozin in real-world patients compared with DPP-IV inhibitors and GLP-1 receptor agonists.

Patients who developed HF at any time after their diabetes diagnosis had the greatest relative and absolute risk for death at 5 years compared with those with diabetes who had other CV or renal diagnoses, researchers reported.